Laurie Keating most recently served as Executive Vice President and Chief Legal Officer at Alnylam Pharmaceuticals, where she led the company’s global public policy and government relations, legal, and intellectual property groups. Prior to joining Alnylam, Laurie served as Senior Vice President, General Counsel and Secretary at Millennium Pharmaceuticals, where she led the legal, intellectual property, corporate quality and compliance groups. Prior to Millennium, Laurie was the founding Chief Executive Officer of Hydra Biosciences, a privately held, venture-backed company, and served on Hydra’s Board for six years.
Laurie currently sits on the Board of Directors for Immuneering Corporation and MassBIO, a non-profit organization dedicated to growing the biopharmaceutical industry, adding value to the healthcare system, and improving patient lives in Massachusetts. She has a bachelor’s degree in economics from the University of California, Berkeley and received her J.D. from the University of California, Hastings College of Law.